The share price of Castle Biosciences, Inc. (CSTL) now
What analysts predict: $45.88
52-week High/Low: $47.27 / $15.58
50/200 Day Moving Average:
$24.98 / $24.85
This figure corresponds to the Average Price over the previous 50/200 days.
For Castle Biosciences stocks, the 50-day moving average is the resistance level today.
For Castle Biosciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Castle Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Castle Biosciences
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one Castle Biosciences share be worth in
2023 - 2027?
When should I take profit in Castle Biosciences stock?
When should I record a loss on Castle Biosciences stock?
What are analysts' forecasts for Castle Biosciences stock?
What is the future of Castle Biosciences stock?
We forecast Castle Biosciences stock performance using neural networks based on historical data on Castle Biosciences stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Castle Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Castle Biosciences shares. This happens once a day.
Historical and forecast chart of Castle Biosciences stock
The chart below shows the historical price of Castle Biosciences stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Castle Biosciences stock price can be found in the table below.
Long-term forecasts by years.
Subscribe for Forecasts Update!
Castle Biosciences daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Mar 25
21.60
21.14
22.24
5.19
Mar 26
21.86
21.22
22.38
5.44
Mar 27
21.54
21.22
21.81
2.80
Mar 28
21.11
20.60
21.45
4.14
Mar 29
21.86
21.49
22.51
4.76
Mar 30
21.96
21.75
22.39
2.91
Mar 31
22.19
21.93
22.71
3.56
Apr 01
22.01
21.75
22.35
2.75
Apr 02
21.62
21.13
21.99
4.05
Apr 03
21.53
21.08
21.76
3.23
Apr 04
20.98
20.43
21.48
5.18
Apr 05
21.03
20.47
21.70
6.04
Apr 06
21.81
21.39
22.16
3.63
Apr 07
21.61
21.37
22.26
4.17
Apr 08
22.05
21.38
22.32
4.37
Apr 09
22.46
22.24
22.65
1.82
Apr 10
22.73
22.53
23.38
3.79
Apr 11
22.51
22.25
22.96
3.20
Apr 12
22.63
22.25
23.05
3.62
Apr 13
22.97
22.69
23.51
3.65
Apr 14
23.19
22.45
23.68
5.50
Apr 15
22.85
22.44
23.15
3.18
Apr 16
23.21
22.59
23.74
5.09
Apr 17
23.93
23.22
24.42
5.15
Apr 18
23.63
23.17
23.94
3.30
Apr 19
23.50
22.75
24.07
5.83
Apr 20
23.82
23.61
24.15
2.30
Apr 21
23.96
23.33
24.68
5.79
Apr 22
23.48
22.94
23.76
3.56
Apr 23
23.77
23.30
24.16
3.67
Castle Biosciences Daily Price Targets
Castle Biosciences Stock Forecast 03-25-2023.
Forecast target price for 03-25-2023: $21.60. Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.934%. Pessimistic target level: 21.14 Optimistic target level: 22.24
Castle Biosciences Stock Forecast 03-26-2023.
Forecast target price for 03-26-2023: $21.86. Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 5.158%. Pessimistic target level: 21.22 Optimistic target level: 22.38
Castle Biosciences Stock Forecast 03-27-2023.
Forecast target price for 03-27-2023: $21.54. Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 2.725%. Pessimistic target level: 21.22 Optimistic target level: 21.81
Castle Biosciences Stock Forecast 03-28-2023.
Forecast target price for 03-28-2023: $21.11. Negative dynamics for Castle Biosciences shares will prevail with possible volatility of 3.975%. Pessimistic target level: 20.60 Optimistic target level: 21.45
Castle Biosciences Stock Forecast 03-29-2023.
Forecast target price for 03-29-2023: $21.86. Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 4.543%. Pessimistic target level: 21.49 Optimistic target level: 22.51
Castle Biosciences Stock Forecast 03-30-2023.
Forecast target price for 03-30-2023: $21.96. Positive dynamics for Castle Biosciences shares will prevail with possible volatility of 2.826%. Pessimistic target level: 21.75 Optimistic target level: 22.39
Castle of Biological Sciences, Inc., a commercial stage dermatological cancer, develops and commercializes diagnostic and prognostic tests for cancers. Its flagship product is DecisionDx-Melanoma, a Multiple Gene Expression Profile (GEP) test for identifying Stage I and II patients at high risk of metastasis, based on biological information from 31 genes in their tumor tissue. The company also offers the DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis in patients with uveal melanoma, a rare eye cancer; and two late-stage proprietary products that address squamous cell skin cancer and suspicious pigmented lesions, which are highly clinical indications for dermatological cancer. It offers testing services through physicians, physician assistants and nurse practitioners. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Castle Biosciences Address
820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US
Market Capitalization:
601 937 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA:
-80 599 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
None
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-2.59
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
-0.926
Quarterly Revenue Growth YOY:
0.531
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
3.251
Enterprise Value (EV) /Revenue
EV To EBITDA:
-7.4
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
26575600
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website